FDA NDC Directory · JSON-LD · Markdown

Donanemab

NDC 43624-044 · DRUG FOR FURTHER PROCESSING · INJECTION, SOLUTION

Labeler / ManufacturerBSP Pharmaceuticals S.p.A.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, SOLUTION
Active ingredientsDONANEMAB (17.5 mg/mL)
Marketing started20260922
Package count1

External sources

Source: openFDA. Public-domain (CC0).